NOX5 and atherosclerosis: In human macrophages, LPS induces the recruitment of p300 and enhances histone acetylation at the sites of active transcription within proximal promoter of NADPH oxidase 5 gene, suggesting that pharmacological targeting of epigenetic-based pathways that control NADPH oxidase 5 expression might be a noteworthy novel therapeutic strategy in atherosclerosis [74].